Cowen Reiterates Zymergen (ZY) at Market Perform, Sees Potential Recovery in Stock on SynBio Opportunity
Tweet Send to a Friend
Cowen analyst Steven Mah reiterated a Market Perform rating on Zymergen Inc (NASDAQ: ZY), following the company's latest quarterly report.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
